Addiction research and treatment: The State of the art in 2008

Psychiatric Times

Volumn 25, Issue 7, 2008, Pages 52-57

  Merlo, Lisa J ^a   Gold, Mark S ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b McKnight Brain Institute

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46849102577     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Regier CA, Farmer ME, Rae DS. Comorbidity of mental disorders with alcohol and other drug abuse results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511-2518.
2. Robinson TE. Neuroscience. Addicted rats. Science. 2004;305:951-953.
3. Risinger RC, Salmeron BJ, Ross TJ, et al. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage. 2005; 26: 1097-1108.
4. Phillips PE, Stuber GD, Heien ML, et al. Subsecond dopamine release promotes cocaine seeking. Nature. 2003;422:614-618.
5. Melis M, Gessa GL, Diana M. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24:993-1006.
6. Balfour DJ. Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence. Curr Drug Targets CNS Neurol Disord. 2002;1:413-421.
7. Gonzales RA, Job MO, Doyon WM. The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol Ther. 2004;103:121-146.
8. Boehm SL 2nd, Ponomarev I, Jennings AW, et al. gamma-Aminobutyric acid A receptor subunit mutant mice: new perspectives on alcohol actions. Biochem Pharmacol. 2004;68:1581-1602.
9. Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine indrug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry. 2004;9:557-569.
10. Dani JA, Ji D, Zhou FM. Synaptic plasticity and nicotine addiction. Neuron. 2001;31:349-352.
11. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97-129.
12. McFarland K, Davidge SB, Lapish CC, Kalivas PW. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci. 2004;24:1551-1560.
13. Naqvi NH, Rudrauf D, Damasio H, Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science. 2007;315:531-534.
14. Kim H, Neubert JK, San Miguel A, et al. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain. 2004;109:488-496.
15. Cossu G, Ledent C, Fattore L, et al. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res. 2001;118:61-65.
16. Fowler JS, Volkow ND, Kassed CA, Chang L. Imaging the addicted human brain. Sci Pract Perspect. 2007;3:4-16.
17. Paulus MP, Tapert SF, Schuckit MA. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry. 2005;62:761-768.
18. Ellgren M, Spano SM, Hurd YL. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology. 2007;32:607-615.
19. Lynskey MT, Heath AC, Bucholz KK, et al. Escalation of drug use in early-onset cannabis users vs cotwin controls. JAMA. 2003;289:427-433.
20. Agrawal A, Neale MC, Prescott CA, Kendler KS. A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med. 2004;34:1227-1237.
21. McAuliffe PF, Gold MS, Bajpai L, et al. Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses. 2006; 66:874-882.
22. Merlo LJ, Goldberger BA, Kolodner D, et al. Fentanyl and propofol exposure in the operating room: sensitization hypotheses and further data. J Addict Dis. In press.
23. Nestler EJ. Molecular basis of long-lived neural plasticity to drugs of abuse. Nat Rev Neurosci. 2001; 2:119-128.
24. Kobeissy FH, Sadasivan S, Liu J, et al. Psychoproteomics, degradomics and systems biology approach to psychiatric research. Exp Revs Proteomics. In press.
25. Kobeissy FH, Warren M, Ottens AK, et al. Psychoproteomic analysis of rat cortex following acute methamphetamine exposure. J Proteome Res. In press.
26. Wang GJ, Volkow ND, Chang L, et al. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry. 2004;161:242-248.
27. Koob GF, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007;164:1149-1159.
28. Mantsch JR, Schlussman SD, Ho A, Kreek MJ. Effects of cocaine self-administration on plasma corticosterone and prolactin in rats. J Pharmacol Exp Ther. 2000;294:239-247.
29. Marlatt GA, Gordon JR, eds. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford Press; 1985.
30. Evans LE, Swainson CP, Roscoe P, et al.Treatment of drug overdosage with naloxone, a specific narcotic antagonist. Lancet. 1973;1:452-455.
31. Roehrich H, Gold MS. Clonidine. Adv Alcohol Subst Abuse. 1987;7:1-16.
32. O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA. 1998;279:229-234.
33. Overman GP, Teter CJ, Guthrie SK. Acamprosate for the adjunctive treatment of alcohol dependence. Ann Pharmacother. 2003;37:1090-1099.
34. Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295:2003-2017.
35. Klingemann H, Sobell LC, eds. Promoting Self-Change from Addictive Behaviors: Practical Implications for Policy, Prevention, and Treatment. New York: Springer; 2007.
36. Miller WR, Rollnick S. Motivational Inteniewing: Preparing People for Change. New York: Guilford Press; 2002.
37. Higgins ST, Silverman K, Heil SH, eds. Contingency Management in Substance Abuse Treatment. New York: Guildford Press; 2008.
38. Stanton MD, Shandish WR. Outcome, attrition, and family couples treatment for drug abuse: a meta-analysis and review of the controlled comparative studies. Psychol Bull. 1997;22:170-191.
39. Chappel JN, DuPont RL. Twelve-step and mutual-help programs for addictive disorders. Psychiatr Clin North Am. 1999;22:425-446.
40. Nowinski J, Baker S. The Twelve-Step Facilitation Handbook: A Systematic Approach to Early Recovery from Alcoholism and Addiction. New York: Lexington Books; 1992.
41. Bogenschutz MP, Geppert CM, George J. The role of twelve-step approaches in dual diagnosis treatment and recovery. Am J Addict. 2006;15:50-60.
42. Zemore SE, Kaskutas LA. Helping, spirituality, and Alcoholics Anonymous in recovery. J Stud Alcohol. 2004;65:383-391.
43. Pagano ME, Friend KB, Tonigan JS, Stout RL. Helping other alcoholics in Alcoholics Anonymous and drinking outcomes: findings from Project MATCH. J Stud Alcohol. 2004;65:766-773.
44. Preston KL, Silverman K, Schuster CR, Cone EJ. Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies. NIDA Res Monogr. 1997;167:130-145.
45. Betty Ford Institute Consensus Panel. What is recovery? a working definition from the Betty Ford Institute. J Subst Abuse Treat. 2007;33:221-228.
46. Skipper GE, Weinmann W, Thierauf A, et al. Ethyl glucuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol Alcohol. 2004;39:445-449.
47. Peace MR, Tarnai LD. Performance evaluation of three on-site adulterant detection devices for urine specimens. J Anal Toxicol. 2002;26:464-470.
48. Cornwell EE, Belzberg H, Velmahos G, et al. The prevalence and effect of alcohol and drug abuse on cohort-matched critically injured patients. Am Surg. 1998;64:461-465.
49. Brownell KD, Marlatt GA, Lichtenstein E, Wilson GT. Understanding and preventing relapse. Am Psychol. 1986;41:765-782.
50. Miller WR, Sanchez-Craig M. How to have a high success rate in treatment: advice for evaluators of alcoholism programs. Addiction. 1996;91:779-785.
51. Domino KB, Hornbein TF, Polissar NL, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA. 2005;293:1453-1460.
52. Talbott G, Gallegos KV, Wilson PO, Porter T. The Medical Association of Georgia's impaired physician's program: review of the first 1000 physicians: analysis of specialty. JAMA. 1987;257:2927-2930.
53. Lloyd G. One hundred alcoholic doctors: a 21-year follow-up. Alcohol Alcohol. 2002;37:370-374.
54. Corsino BV, Morrow DH, Wallace CJ. Quality improvement and substance abuse: rethinking impaired provider policies. Am J Med Qual. 1996;11:94-99.
55. Carpenter C, Cook PJ. Cigarette taxes and youth smoking: new evidence from national, state, and local youth risk behavior surveys. J Health Econ. 2008;27:287-299.
56. Wagenaar AC, Maldonado-Molina M, Wagenaar BH. Effects of alcohol tax increases on disease mortality in Alaska: time-series analyses from 1976 to 2004. Am J Public Health. In press.
57. Block LG, Morwitz VG, Putsis WP Jr, Sen SK. Assessing the impact of antidrug advertising on adolescent drug consumption: results from a behavioral economic model. Am J Public Health. 2002;92:1346-1351.
58. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future: National Survey Results on Drug Use, 1975-2006. www.monitoringthefuture. org/pubs/monographs/vol1_2006.pdf. Accessed April 28, 2008.
59. Goldberger BA, Graham NA, Nelson SJ, et al. A marked increase in cocaine-related deaths in the state of Florida: precursor to an epidemic? J Addict Dis. 2007;26:113-116.
60. Graham NA, Merlo LJ, Goldberger BA, Gold MS. Methadone- and heroin-related deaths in Florida. Am J Drug Alcohol Abuse. 2008;34:347-353.
61. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci. 2005;8:1445-1449.
62. Kelley AE, Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci. 2002;22:3306-3311.
63. Avena NM, Rada P, Moise N, Hoebel BG. Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response. Neuroscience. 2006;139:813-820.
64. Black DW. The epidemiology and phenomenology of compulsive sexual behavior. CNS Spectr. 2000;5:26-72.
65. Dannon PN, Lowengrub K, Shalgi B, et al. Dual psychiatric diagnosis and substance abuse in pathological gamblers: a preliminary gender comparison study. J Addict Dis. 2006;25:49-54.
66. Wilfley DE, Friedman MA, Dounchis JA, et al. Comorbid psychopathology in binge eating disorder: relation to eating disorder severity at baseline and following treatment. J Consult Clin Psychol. 2000;68:641-649.
67. Hodgkins CC, Jacobs WS, Gold MS. Weight gain after adolescent drug addiction treatment and supervised abstinence. Psychiatr Ann. 2003;33:112-117.
68. Betty Ford Institute Consensus Panel. What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat. 2007;33:221-228.
69. Fowler JS, Volkow ND, Kassed CA, Chang L. Imaging the addicted human brain. Sci Pract Perspect. 2007;3: 4-16.